IE32344B1 - Halogenated steroids and process for the manufacture thereof - Google Patents

Halogenated steroids and process for the manufacture thereof

Info

Publication number
IE32344B1
IE32344B1 IE949/68A IE94968A IE32344B1 IE 32344 B1 IE32344 B1 IE 32344B1 IE 949/68 A IE949/68 A IE 949/68A IE 94968 A IE94968 A IE 94968A IE 32344 B1 IE32344 B1 IE 32344B1
Authority
IE
Ireland
Prior art keywords
acetoxy
chloro
trione
pregna
diene
Prior art date
Application number
IE949/68A
Other versions
IE32344L (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IE32344L publication Critical patent/IE32344L/en
Publication of IE32344B1 publication Critical patent/IE32344B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)

Abstract

1,215,752. 4-Chloro-steroids. F. HOFFMANNLA ROCHE & CO. A.G. 6 Aug., 1968 [7 Aug., 1967], No. 37510/68. Heading C2U. The invention comprises steroids of formula wherein R<SP>1</SP> is F, Cl, Br or C 1-8 alkyl, and A represents one of the following entities wherein R<SP>2</SP> is H or F; R<SP>3</SP> is H, OH, C 1-8 alkoxy, C 1-8 alkanoyloxy, COCHF 2 , COCHCl 2 or C 1-8 alkyl; R<SP>4</SP> is C 1-7 alkylidene or α-CH 2 Cl, (the latter, only when n is 0 or 1, X is a #<SP>1</SP>-unsaturation or 2-chloro group, R<SP>2</SP> is H and R<SP>3</SP> is OH or C 1-8 alkanoyloxy); or R<SP>3</SP> + R<SP>4</SP> together form a 1<SP>1</SP>-alkyl-alkylidenedioxy group; R<SP>5</SP> is H or C 1-8 alkanoyl; R<SP>6</SP> is H, C 1-8 alkyl or optionally halo-substituted C 2-7 monounsaturated aliphatic hydrocarbyl; R<SP>7</SP> is H or CH 3 ; R<SP>8</SP> is α-H, α-F, α-Cl or α-Br; R<SP>9</SP> is H, a hydroxy group, the dihydrogen phosphate ester thereof or an alkali metal salt thereof, or a C 1-8 alkanoyloxy group; R<SP>10</SP> is C 1-7 alkylidene, α-CH 2 Cl, α-CH 2 F, α-Cl or α-F; R<SP>11</SP> is OH or C 1-8 alkanoyloxy; or, when R<SP>9</SP> is H, R<SP>10</SP> + R<SP>11</SP> together form a 1<SP>1</SP>-alkylalkylidenedioxy group; or R<SP>9</SP> + R<SP>11</SP> together form a 1<SP>1</SP>-alkoxy-alkylidenedioxy group; n is 0 or 1; X is a #<SP>1</SP>-unsaturation or a 2-chloro or 1α,2α-methylene group; X<SP>1</SP> is a #<SP>1</SP>-unsaturation or a 2-chloro group; Y is CH 2 , CHOH or CO; Z is CHOH, CO, α-(alkyl- or aryl-sulphonyloxy) - methylene or, (when R<SP>8</SP> is α-H and R<SP>9</SP> is other than H), methylene, or, (when R<SP>8</SP> = Cl), #-chloromethylene; or x + R<SP>8</SP> together represent a #<SP>9</SP>(<SP>11</SP>)-unsaturation or a 9#, 11#-epoxy group. The above compounds are prepared (i) by chlorination of the corresponding 4-unsubstituted compounds; and (ii) the action of a strong acid on a steroid of formula to obtain the corresponding 16-methylene-17α- hydroxy-steroid. Product interconversions described are 2-chlorination; 1,2-dehydrogenation; oxidation of 11-OH to 11-OXO; sulphonation of 11α-OH; dehydration of a 9α-H-11#-OH compound or desulphonation of a 9α-H-11α- sulphonyloxy compound to yield a #<SP>9</SP>(<SP>11</SP>)- compound; treatment of #<SP>9</SP>(<SP>11</SP>)-compounds with HOCl or HOBr to give 9α-(Cl or Br)-11-OH compounds; dehydrohalogenating 9α-(Cl or Br)-11-OH compounds to 9#,11#-epoxy compounds; treatment of 9#,11#-epoxy compounds with HF, HCl, HBr or a chlorinating agent to give 9α-halo-11-OH or 9α,11#-dichloro compounds; esterification of 17- and/or 21-hydroxy groups; and saponification of 17- and/or 21-alkanoyloxy groups. 6 - Fluoro - 16α,17α - isopropylidenedioxypregna - 4,6 - diene - 3,11,20 - trione, 21 - acetoxy - 6 - fluoro - 16α - fluoromethyl - 17α - hydroxy - pregna - 4,6 - diene 3,11,20 - triene and 21 - acetoxy - 6,16α - difluoro - 17α - hydroxypregna - 4,6 - diene - 3,11,20 - trione are prepared by 6,7-dehydrogenation of the corresponding pregn-4-enes. 6 - Chloro - 16α - chloromethyl - 17α - acetoxypregna - 4,6 - diene - 3,20 - dione is prepared from 16α - chloromethyl - 17α - acetoxy - pregn- 4 - ene - 3,20 - dione via 17α - acetoxy - 16α chloromethyl - 3 - ethoxy - pregna - 3,5 - dien - 20- one and 6# - chloro - 16α - chloromethyl - 17α- acetoxy - pregn - 4 - ene - 3,20 - dione. 21 - Acetoxy - 6 - chloro - 17α - hydroxy - 16- methylene - pregna - 4,6 - diene - 3,11,20 - trione is prepared from 21-acetoxy-17α-hydroxy-16- methylene - pregn - 4 - ene - 3,11,20 - trione via 21 - acetoxy - 3 - ethoxy - 17α - hydroxy - 16- methylene - pregna - 3,5 - diene - 11,20 - dione and 21 - acetoxy - 6# - chloro - 17α - hydroxy - 16- methylene - pregn - 4 - ene - 3,11,20 - trione. 4,6 - Dichloro - 21 - acetoxy - 16α,17α - epoxy- 16# - methyl - pregna - 4,6 - diene - 3,11,20- trione (X) is prepared by the sequence: 21- acetoxy - 6 - chloro - 17α - hydroxy - pregna - 4,6- diene - 3,11,20 - trione (XI) # the 3,20 - bis- (semicarbazone) of XI # 21 - acetoxy - 6- chloro - pregna - 4,6,16 - triene - 3,11,20 - trione 3,20 - bis(semicarbazone) # 21 - hydroxy - 6- chloro - pregna - 4,6,16 - triene - 3,11,20 - trione (XII) # the 21-acetate of XII # 6-chloro-21- acetoxy - 16α,17α - methyleneazo - pregna - 4,6- diene - 3,11,20 - trione # 6 - chloro - 21 - acetoxy - 16 - methyl - pregna - 4,6,16 - triene- 3,11,20 - trione # an unidentified trichloro intermediate (by treatment with Cl 2 /CCl 4 ) # an unidentified oil (by treatment with Na 2 HPO 4 / CF 3 CO 3 H) # X (by treatment with pyridine). 2#,4,6 - Trichloro - 21 - acetoxy - 16α,17α- epoxy - 16# - methyl - pregna - 4,6 - diene- 3,11,20-trione is prepared by chlorination of the corresponding 2-dechloro compound. The compounds of Formula I are stated to possess progestational, glucocorticoid, mineralocorticoid, anti inflammatory and thymolytic activities, and may be made up with carriers into pharmaceutical compositions for oral, parenteral and topical administration. [GB1215752A]
IE949/68A 1967-08-07 1968-08-06 Halogenated steroids and process for the manufacture thereof IE32344B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65860267A 1967-08-07 1967-08-07

Publications (2)

Publication Number Publication Date
IE32344L IE32344L (en) 1969-02-07
IE32344B1 true IE32344B1 (en) 1973-06-27

Family

ID=24641922

Family Applications (2)

Application Number Title Priority Date Filing Date
IE950/68A IE32397B1 (en) 1967-08-07 1968-08-06 Halogenated steroids and process for the manufacture thereof
IE949/68A IE32344B1 (en) 1967-08-07 1968-08-06 Halogenated steroids and process for the manufacture thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IE950/68A IE32397B1 (en) 1967-08-07 1968-08-06 Halogenated steroids and process for the manufacture thereof

Country Status (17)

Country Link
JP (2) JPS5021474B1 (en)
AT (4) AT290031B (en)
BE (2) BE719050A (en)
CH (10) CH544073A (en)
DE (1) DE1793063A1 (en)
DK (2) DK126187B (en)
ES (2) ES356956A1 (en)
FI (2) FI45321C (en)
FR (4) FR8417M (en)
GB (2) GB1217530A (en)
IE (2) IE32397B1 (en)
IL (2) IL30491A (en)
MY (1) MY7100216A (en)
NL (2) NL6811217A (en)
NO (2) NO128765B (en)
SE (2) SE351633B (en)
YU (2) YU33190B (en)

Also Published As

Publication number Publication date
ES356956A1 (en) 1970-02-16
IL30492A0 (en) 1968-10-24
FI45322B (en) 1972-01-31
FR1588547A (en) 1970-04-17
YU33190B (en) 1976-06-30
FI45322C (en) 1972-05-10
FR8417M (en) 1971-06-10
DK122606B (en) 1972-03-20
IL30491A (en) 1973-06-29
YU185768A (en) 1975-08-31
CH544073A (en) 1973-12-28
NO128765B (en) 1974-01-07
DE1793063A1 (en) 1971-07-08
CH565198A5 (en) 1975-08-15
MY7100216A (en) 1971-12-31
FI45321B (en) 1972-01-31
SE351633B (en) 1972-12-04
AT290031B (en) 1971-03-15
JPS5010859B1 (en) 1975-04-24
JPS5021474B1 (en) 1975-07-23
DE1793064A1 (en) 1971-12-16
CH544074A (en) 1973-12-28
CH544075A (en) 1973-12-28
IL30491A0 (en) 1968-10-24
NL6811218A (en) 1969-02-11
IL30492A (en) 1973-03-30
GB1215752A (en) 1970-12-16
FI45321C (en) 1972-05-10
AT290030B (en) 1971-05-10
BE719050A (en) 1969-02-05
CH541550A (en) 1973-10-31
DE1793064B2 (en) 1977-01-20
CH544081A (en) 1973-12-28
YU185868A (en) 1975-12-31
IE32397B1 (en) 1973-07-25
FR1588548A (en) 1970-04-17
CH541549A (en) 1973-10-31
IE32344L (en) 1969-02-07
IE32397L (en) 1969-02-07
ES356957A1 (en) 1970-02-16
NO128766B (en) 1974-01-07
BE719049A (en) 1969-02-05
FR7921M (en) 1970-05-19
GB1217530A (en) 1970-12-31
CH544076A (en) 1973-12-28
NL6811217A (en) 1969-02-11
DK126187B (en) 1973-06-18
SE351632B (en) 1972-12-04
AT285833B (en) 1970-11-10
AT285832B (en) 1970-11-10
CH544072A (en) 1973-12-28
CH555329A (en) 1974-10-31

Similar Documents

Publication Publication Date Title
EP0135476A2 (en) Carboxylic acid esters of steroids
US2774775A (en) Carbonyloxy steroids
US2865935A (en) 2-methyl steroids and process
GB869511A (en) Improvements in or relating to steroids and the manufacture thereof
IE32344B1 (en) Halogenated steroids and process for the manufacture thereof
US3164618A (en) Alkylated steroids
US3072686A (en) 16alpha-alkyl-pregnane compounds and process for their manufacture
US3793350A (en) Process for preparing 17alpha,21-dihydroxy-20-keto-pregnanes,derivatives and intermediates thereof
US3105840A (en) Alkyl ethers of 17alpha-hydroxy-19-nor progesterone
GB1247641A (en) 9alpha-FLUORO-16-FLUOROMETHYLENEPREDNISOLONE-21-ESTER AND PREPARATION THEREOF
US3079301A (en) 9alpha-halo-1, 4, 6-pregnatrienes and therapeutic compositions containing same
US3660435A (en) 3 16alpha 17alpha-trihydroxy-delta1 3 5(10)-oestratriene
US3438977A (en) 6,7-methylene and 6,7-halomethylene pregnanes and 19-norpregnanes and process for their preparation
US3519619A (en) 16-alkylidene pregnanes and process for their manufacture
US3047596A (en) 6alpha-halogen-9alpha-halogen-delta-pregnadiene-3-one compounds
GB924931A (en)
DE1193941B (en) Process for the preparation of therapeutically effective 16beta-alkyl-9alpha-fluoro-11beta, 17alpha, 21-trioxy-4-pregnen-3, 20-dione-21-acylates or the corresponding 2
US3415855A (en) Trichloro pregnadienes and esters thereof
DE1037452B (en) Process for the preparation of 6-halo-4-pregnene-11ª‰, 17ª‡, 21-triol-3, 20-dione and 6-halo-4-pregnene-17ª‡, 21-diol-3, 11, 20- trions and their 21-acylates
IE35896B1 (en) New 6alpha-fluoro-16alpha,18-dimethyl-delta1,4-pregnadiene-3,20-diones
DE1593518C3 (en) Process for the preparation of a 17 alpha-ester of the pregnane series
US3803182A (en) Disteroidyl-ethers
JPS54119446A (en) Preparation of estrone
US3163664A (en) 21-hemi-alpha, beta-dialkylsuccinates of corticoids
US3043855A (en) 16-ethers of 16, 17-dihydroxy steroids of the pregnane series